Division of Laboratory Systems (DLS)
What's New
- CMS Updates CLIA Surveyor Guidance for SARS-CoV-2 Reporting
- FDA Updates Reporting Guidance, Authorizes Update to IFU for Multiplex Assay
- FDA: Genetic Variants of SARS-CoV-2 and False Negative Results with Molecular Tests
- FDA: Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19
- CDC Offers New Infographics for SARS-CoV-2 Point-of-Care Tests
DLS Vision
Exemplary laboratory science and practice advance clinical care, public health, and health equity.
DLS Mission
Improve public health, patient outcomes, and health equity by advancing clinical and public health laboratory quality and safety, data and biorepository science, and workforce competency.
Key Resources
- Preparing and Supporting Laboratories Responding to COVID-19
- LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests
- Biosafety Guidelines for Handling and Processing COVID-19 Specimens
- Waived Testing Educational Materials
- Laboratory Communicators’ Network (LCN)
- Competency Guidelines for Laboratory Professionals
- DLS Publications
- Free Educational Materials
- Medical Laboratory Professionals Week (Lab Week)
- Enhancing Public Health Laboratory Capabilities and Increasing Capacity OE20-2001
Page last reviewed: January 22, 2021
Content source: Division of Laboratory Systems (DLS)